Caregen is a publicly listed
global leader in peptide biotechnology (KOSDAQ: 214370), headquartered in South
Korea. Since 2001, we have focused on advancing human health through peptide
innovation, developing over 1,400 proprietary peptides and securing more than
800 global patents across pharmaceuticals, nutraceuticals, medical aesthetics,
and functional foods.
Guided by our core
philosophy, “We don’t sell what doesn’t work,” Caregen is committed to
scientific integrity and proven efficacy. Backed by over 20 years of research,
100+ R&D specialists, and extensive clinical validation, our products
deliver reliable, science-based solutions that support metabolic health,
wellness, and healthy aging.
Beyond research, Caregen
operates a fully integrated value chain from peptide design to global
commercialization, exporting to over 130 countries worldwide. With continuous
innovation and strong market recognition, we are committed to redefining
longevity and improving quality of life for people around the world
| Primary business activity | Manufacturer: Ingredients / Additives |
|---|---|
| Affiliated categories: | Collagen peptides |Other Amino acids |Other Bioactives More |